{
    "Title": "The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection",
    "URL": "https://doi.org/10.1371/journal.pntd.0005540",
    "Published": "April 12, 2017",
    "Subject_Areas": [
        "Ebola virus",
        "Endosomes",
        "Phase II clinical investigation",
        "Macrophages",
        "Transfection",
        "Cytoplasm",
        "Drug therapy",
        "Cholesterol"
    ],
    "Authors": {
        "Elizabeth A. Nelson": [
            "Department of Cell Biology, University of Virginia, Charlottesville, Virginia, United States of America"
        ],
        "Julie Dyall": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Thomas Hoenen": [
            "Laboratory of Virology, Division of Intramural Research, National Institutes of Health, Hamilton, Montana, United States of America",
            "Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald\u2013Insel Riems, Germany"
        ],
        "Alyson B. Barnes": [
            "Department of Cell Biology, University of Virginia, Charlottesville, Virginia, United States of America"
        ],
        "Huanying Zhou": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Janie Y. Liang": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Julia Michelotti": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "William H. Dewey": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Lisa Evans DeWald": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Richard S. Bennett": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Patrick J. Morris": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Rajarshi Guha": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Carleen Klumpp-Thomas": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Crystal McKnight": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Yu-Chi Chen": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Xin Xu": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Amy Wang": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Emma Hughes": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Scott Martin": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Craig Thomas": [
            "Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Peter B. Jahrling": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America",
            "Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Lisa E. Hensley": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Gene G. Olinger Jr.": [
            "Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America"
        ],
        "Judith M. White": [
            "Department of Cell Biology, University of Virginia, Charlottesville, Virginia, United States of America"
        ]
    }
}